
According to data from Benzinga Pro, during Q1, Arcadia Biosciences's (NASDAQ:RKDA) reported sales totaled $3.22 million. Despite a 51.76% increase in earnings, the company posted a loss of $4.61 million. Arcadia Biosciences collected $2.17 million in revenue during Q4, but reported earnings showed a $9.56 million loss.